TEST TRIAL - Content Placeholder
/Summary
Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata sanctus est Lorem ipsum dolor sit amet. Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata sanctus est Lorem ipsum dolor sit amet.
What is the optimal dose of intravenous thrombolysis?
Should thrombolysis be administered before or after endovascular thrombectomy in eligible patients?
Can neuroprotective therapies effectively prevent brain cell death when combined with thrombolysis?
What is the ideal blood pressure target following thrombectomy?
By systematically evaluating these critical interventions, ACT-GLOBAL seeks to identify the best evidence-based approaches to improve outcomes for stroke patients worldwide.
Primary Video: https://youtu.be/7wiQWxSCXUg
Participation Invitation
We are actively seeking additional trial sites to join this initiative. Your participation can help shape the future of stroke care, contributing to improved outcomes for patients globally.
Contact Information
For more information or to express interest in joining the ACT-GLOBAL trial, please contact:
Email: info@actglobaltrial.org, docbijoymenon@gmail.com, ademchuk@ucalgary.ca
Website: Visit the ACT-GLOBAL trial site
We look forward to collaborating with you !